CN Patent

CN113599687B — 具有可分离微针的药物递送装置

Assigned to Georgia Tech Research Corp · Expires 2024-03-08 · 2y expired

What this patent protects

本申请涉及一种具有可分离微针的药物递送装置。装置(400、500)包含能够从药物递送装置分离、控制药物释放速率和/或方向，或其组合的微针(450、550)。当所述微针可分离时，施加到所述药物递送装置的力能够有效地用所述微针穿透生物组织并且接着从所述药物递送装置分离所述微针。所述药物递送装置可能够实现离散的药物释放期。

USPTO Abstract

本申请涉及一种具有可分离微针的药物递送装置。装置(400、500)包含能够从药物递送装置分离、控制药物释放速率和/或方向，或其组合的微针(450、550)。当所述微针可分离时，施加到所述药物递送装置的力能够有效地用所述微针穿透生物组织并且接着从所述药物递送装置分离所述微针。所述药物递送装置可能够实现离散的药物释放期。

Drugs covered by this patent

triamcinolone-acetonide (TRIAMCINOLONE ACETONIDE)

Patent Metadata

Patent number: CN113599687B
Jurisdiction: CN
Classification: —
Expires: 2024-03-08
Drug substance claim: No
Drug product claim: No
Assignee: Georgia Tech Research Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.